Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Dutasteride may help reduce brain inflammation and improve cognition.

Atorvastatin may cause hair loss in some people.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

The microneedle patch with quercetin, zinc, and copper effectively promotes hair regrowth for androgenic alopecia.

Liver enzyme helps minoxidil work better for blood vessel relaxation.

Inclisiran is effective at lowering cholesterol.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Afatinib often causes skin problems that need proactive management.

Different zinc compounds cause varying levels of skin irritation in animals.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.